KAYSKaya Holdings, Inc.

About Kaya Holdings, Inc. (KAYS)

Kaya Holdings, Inc. (KAYS) is a Drug Manufacturers - Specialty & Generic company headquartered in Fort Lauderdale, FL, United States whose shares trade over-the-counter on the OTCQB tier.

Kaya Holdings is a "mind care" company focusing on wellness and mental health through operations in psychedelic treatments and medical and recreational cannabis operations. KAYS majority-owned subsidiary Fifth Dimension Therapeutics, Inc. has been awarded its license to own and operate a Psilocybin Service Center by the Oregon Health Authority (the "OHA"), making KAYS the first publicly traded company to own and operate a U.S. based psilocybin treatment center. Oregon is the only state in the US that has developed a licensing framework that allows for the administration of Psilocybin in a safe, legal setting under the guidance of State Licensed Facilitators. The Company's full-service psychedelic treatment center will allow clients to receive psilocybin treatments in a setting offering significant experience differentiators and concept innovations, and our Licensed Facilitators are working to begin treating guests within the next 30 days. In 2014 KAYS became the first U.S. public company to own and operate a medical cannabis dispensary, and is resuming its role as an innovator and trend setter as it seeks to address shortfalls in the U.S. Behavioral Health Market that is expected to exceed $136 Billion by 2032.

Products and services

Our SIC Classification is 2834- Pharmaceutical Preparations. KAYS’ OHA Licensed Psilocybin Service Center in Portland, Oregon offers clients access to laboratory-tested Psilocybin Mushrooms and Psilocin Extract products. Our Medical Cannabis Production and Processing Facility in Epidaurus, Greece will offer cannabis medical patients access to cannabis, and cannabis extracted and infused products based on our strain library of over 150 core cannabis strains and 10 years of operating history in Oregon.

KAYS key facts

Ticker symbol

KAYS

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Fort Lauderdale, FL, United States

Country of incorporation

US

Employees

3

Estimated market cap

$1.62M (as of Apr 11, 2025)

Shares outstanding

41,572,835

Reporting standard

U.S. Reporting: SEC Reporting

Audit status

Audited

Fiscal year end

12/31

Kaya Holdings, Inc. leadership

• Craig Frank — CEO, CFO, President
• W. David Jones — Consultant

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with K